Zhihui Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhihui Yang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Dabing Li
Department of Physiology, School of Basic Medical Sciences, Southwestern Medical University, LuZhou, China
14 shared publications Fiona T. Bane
14 shared publications- Jean Ching-Yi Tien
Michigan Center for Translational Pathology, University of Michigan
14 shared publications Jianming Xu
14 shared publicationsLan Liao
14 shared publications- Leonie S. Young
Department of Surgery, RCSI University of Medicine and Health Sciences, Dublin, Ireland
14 shared publications
Latest Publications
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Data from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
In breast cancer, overexpression of the nuclear coactivator NCOA1 (SRC-1) is associated with disease recurrence and resistance to endocrine therapy. To examine the impact of NCOA1 overexpression on morphogenesis and carcinogenesis in the mammary gland (MG), we generated MMTV-hNCOA1 transgenic [Tg(NCOA1)] mice. In the context of two distinct transgenic models of breast cancer, NCOA1 overexpression did not affect the morphology or tumor-forming capability of MG epithelial cells. However, NCOA1 overexpression increased the number of circulating breast cancer cells and the efficiency of lung metastasis. Mechanistic investigations showed that NCOA1 and c-Fos were recruited to a functional AP-1 site in the macrophage attractant CSF1 promoter, directly upregulating colony-simulating factor 1 (CSF1) expression to enhance macrophage recruitment and metastasis. Conversely, silencing NCOA1 reduced CSF1 expression and decreased macrophage recruitment and breast cancer cell metastasis. In a cohort of 453 human breast tumors, NCOA1 and CSF1 levels correlated positively with disease recurrence, higher tumor grade, and poor prognosis. Together, our results define an NCOA1/AP-1/CSF1 regulatory axis that promotes breast cancer metastasis, offering a novel therapeutic target for impeding this process. Cancer Res; 74(13); 3477–88. ©2014 AACR.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
In breast cancer, overexpression of the nuclear coactivator NCOA1 (SRC-1) is associated with disease recurrence and resistance to endocrine therapy. To examine the impact of NCOA1 overexpression on morphogenesis and carcinogenesis in the mammary gland (MG), we generated MMTV-hNCOA1 transgenic [Tg(NCOA1)] mice. In the context of two distinct transgenic models of breast cancer, NCOA1 overexpression did not affect the morphology or tumor-forming capability of MG epithelial cells. However, NCOA1 overexpression increased the number of circulating breast cancer cells and the efficiency of lung metastasis. Mechanistic investigations showed that NCOA1 and c-Fos were recruited to a functional AP-1 site in the macrophage attractant CSF1 promoter, directly upregulating colony-simulating factor 1 (CSF1) expression to enhance macrophage recruitment and metastasis. Conversely, silencing NCOA1 reduced CSF1 expression and decreased macrophage recruitment and breast cancer cell metastasis. In a cohort of 453 human breast tumors, NCOA1 and CSF1 levels correlated positively with disease recurrence, higher tumor grade, and poor prognosis. Together, our results define an NCOA1/AP-1/CSF1 regulatory axis that promotes breast cancer metastasis, offering a novel therapeutic target for impeding this process. Cancer Res; 74(13); 3477–88. ©2014 AACR.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Data from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
In breast cancer, overexpression of the nuclear coactivator NCOA1 (SRC-1) is associated with disease recurrence and resistance to endocrine therapy. To examine the impact of NCOA1 overexpression on morphogenesis and carcinogenesis in the mammary gland (MG), we generated MMTV-hNCOA1 transgenic [Tg(NCOA1)] mice. In the context of two distinct transgenic models of breast cancer, NCOA1 overexpression did not affect the morphology or tumor-forming capability of MG epithelial cells. However, NCOA1 overexpression increased the number of circulating breast cancer cells and the efficiency of lung metastasis. Mechanistic investigations showed that NCOA1 and c-Fos were recruited to a functional AP-1 site in the macrophage attractant CSF1 promoter, directly upregulating colony-simulating factor 1 (CSF1) expression to enhance macrophage recruitment and metastasis. Conversely, silencing NCOA1 reduced CSF1 expression and decreased macrophage recruitment and breast cancer cell metastasis. In a cohort of 453 human breast tumors, NCOA1 and CSF1 levels correlated positively with disease recurrence, higher tumor grade, and poor prognosis. Together, our results define an NCOA1/AP-1/CSF1 regulatory axis that promotes breast cancer metastasis, offering a novel therapeutic target for impeding this process. Cancer Res; 74(13); 3477–88. ©2014 AACR.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
In breast cancer, overexpression of the nuclear coactivator NCOA1 (SRC-1) is associated with disease recurrence and resistance to endocrine therapy. To examine the impact of NCOA1 overexpression on morphogenesis and carcinogenesis in the mammary gland (MG), we generated MMTV-hNCOA1 transgenic [Tg(NCOA1)] mice. In the context of two distinct transgenic models of breast cancer, NCOA1 overexpression did not affect the morphology or tumor-forming capability of MG epithelial cells. However, NCOA1 overexpression increased the number of circulating breast cancer cells and the efficiency of lung metastasis. Mechanistic investigations showed that NCOA1 and c-Fos were recruited to a functional AP-1 site in the macrophage attractant CSF1 promoter, directly upregulating colony-simulating factor 1 (CSF1) expression to enhance macrophage recruitment and metastasis. Conversely, silencing NCOA1 reduced CSF1 expression and decreased macrophage recruitment and breast cancer cell metastasis. In a cohort of 453 human breast tumors, NCOA1 and CSF1 levels correlated positively with disease recurrence, higher tumor grade, and poor prognosis. Together, our results define an NCOA1/AP-1/CSF1 regulatory axis that promotes breast cancer metastasis, offering a novel therapeutic target for impeding this process. Cancer Res; 74(13); 3477–88. ©2014 AACR.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
PDF file - 198KB, Mammary tumor growth and metastasis in Tg(TVA)+RCAS-PyMT and Tg(NCOA1)x Tg(TVA)+RCAS-PyMT mice.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
PDF file - 198KB, Mammary tumor growth and metastasis in Tg(TVA)+RCAS-PyMT and Tg(NCOA1)x Tg(TVA)+RCAS-PyMT mice.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
PDF file - 368KB, Mammary gland morphogenesis and epithelial proliferation of Tg(NCOA1) mice.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
PDF file - 368KB, Mammary gland morphogenesis and epithelial proliferation of Tg(NCOA1) mice.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Methods from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
PDF file - 93KB, PCR Primers and TaqMan qPCR Probes.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
PDF file - 93KB, PCR Primers and TaqMan qPCR Probes.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
PDF file - 72KB, Positive controls for transfection assays.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
PDF file - 72KB, Positive controls for transfection assays.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
PDF file - 69KB, qPCR measurement of NCOA1 mRNA and mCsf1 mRNA in Tg(Neu) and Tg(NCOA1)xTg(Neu) mouse mammary gland tumor cells transfected with non-targeting control siRNA, NCOA1 siRNA, or mCsf1 siRNA.
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
PDF file - 69KB, qPCR measurement of NCOA1 mRNA and mCsf1 mRNA in Tg(Neu) and Tg(NCOA1)xTg(Neu) mouse mammary gland tumor cells transfected with non-targeting control siRNA, NCOA1 siRNA, or mCsf1 siRNA.
- Open Access
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Methods from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis
- 30 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods from NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis